MA39122A1 - Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors. - Google Patents
Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors.Info
- Publication number
- MA39122A1 MA39122A1 MA39122A MA39122A MA39122A1 MA 39122 A1 MA39122 A1 MA 39122A1 MA 39122 A MA39122 A MA 39122A MA 39122 A MA39122 A MA 39122A MA 39122 A1 MA39122 A1 MA 39122A1
- Authority
- MA
- Morocco
- Prior art keywords
- diseases
- diabetic
- tetrahydrochinolines
- micro
- peripheral
- Prior art date
Links
- STWMVDMOJPLMPX-UHFFFAOYSA-N 1-piperidin-1-yl-3,4-dihydro-2h-quinoline Chemical group C1CCCCN1N1C2=CC=CC=C2CCC1 STWMVDMOJPLMPX-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000674 adrenergic antagonist Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000002093 peripheral effect Effects 0.000 abstract 2
- 206010061666 Autonomic neuropathy Diseases 0.000 abstract 1
- 201000002829 CREST Syndrome Diseases 0.000 abstract 1
- 208000008960 Diabetic foot Diseases 0.000 abstract 1
- 206010056340 Diabetic ulcer Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010022562 Intermittent claudication Diseases 0.000 abstract 1
- 208000003782 Raynaud disease Diseases 0.000 abstract 1
- 208000012322 Raynaud phenomenon Diseases 0.000 abstract 1
- 208000001435 Thromboembolism Diseases 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 201000009101 diabetic angiopathy Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 208000021156 intermittent vascular claudication Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000004089 microcirculation Effects 0.000 abstract 1
- 230000003836 peripheral circulation Effects 0.000 abstract 1
- 208000027232 peripheral nervous system disease Diseases 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne de nouvelles pipéridinyl-tétrahydrochinolines substituées, leur procédé de production, leur utilisation dans le traitement et/ou la prévention de maladies ainsi que leur utilisation dans la production de médicaments destinés au traitement de maladies, notamment au traitement et/ou à la prévention des maladies suivantes : micro-angiopathies diabétiques, ulcères diabétiques aux extrémités, notamment pour favoriser la cicatrisation d'ulcères du pied diabétiques, insuffisance cardiaque diabétique, maladies cardiaques micro-vasculaires diabétiques, maladies vasculaires périphérique et cardiaque, maladies thromboemboliques et ischémies, troubles de la circulation périphérique, phénomène de raynaud, syndrome crest, troubles de la micro-circulation, claudication intermittente et neuropathies périphérique et autonome.The present invention relates to novel substituted piperidinyl tetrahydrochinolines, to a process for their production, to their use in the treatment and / or prevention of diseases and their use in the production of medicaments for the treatment of diseases, in particular treatment and / or the prevention of the following diseases: diabetic micro-angiopathies, diabetic ulcers at the extremities, in particular to promote the healing of diabetic foot ulcers, diabetic heart failure, diabetic micro-vascular heart diseases, peripheral and cardiac vascular diseases, thromboembolic diseases and ischemia, peripheral circulation disorders, raynaud phenomenon, crest syndrome, micro-circulation disorders, intermittent claudication and peripheral and autonomic neuropathies.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13198385 | 2013-12-19 | ||
| PCT/EP2014/077862 WO2015091414A2 (en) | 2013-12-19 | 2014-12-16 | Substituted piperidinyl-tetrahydroquinolines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA39122A1 true MA39122A1 (en) | 2017-11-30 |
| MA39122B1 MA39122B1 (en) | 2018-04-30 |
Family
ID=49876400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39122A MA39122B1 (en) | 2013-12-19 | 2014-12-16 | Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors. |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR098788A1 (en) |
| MA (1) | MA39122B1 (en) |
-
2014
- 2014-12-16 MA MA39122A patent/MA39122B1/en unknown
- 2014-12-17 AR ARP140104708A patent/AR098788A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AR098788A1 (en) | 2016-06-15 |
| MA39122B1 (en) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA34721B1 (en) | SUBSTITUTED 1-BENZYLCYCLOALKYL CARBOXYLIC ACIDS AND USE THEREOF | |
| MA35365B1 (en) | Ringed Pyrimidines substituted and their use | |
| MY177393A (en) | Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists | |
| MA34248B1 (en) | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE | |
| MA42376A (en) | SUBSTITUTED OXOPYRIDINE DERIVATIVES | |
| MA38349A1 (en) | Estra-1,3,5 (10), 16-tetraeno-3-carboxamide to inhibit 17-beta-hydroxysteroid dehydrogenase (akr1c3) | |
| MA33123B1 (en) | 2-Astmedo-5-aryl-1,2,4-triazolone substitute and its use | |
| MA38365A1 (en) | Ringed pyrimidines with trifluoromethyl substitution and corresponding use | |
| PH12016501146A1 (en) | Substituted piperidinyl - tetrahydroquinolines | |
| EP2320933A4 (en) | THERAPEUTIC DOSAGE OF NEUREGULIN OR SUB-SEQUENCE FOR THE TREATMENT OR PROPHYLAXIS OF HEART FAILURE | |
| MA31535B1 (en) | SUBSTITUTED (OXAZOLIDINON-5-YL-METHYL) -2-THIOPHENER CARBOXAMIDES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION | |
| EA202091446A1 (en) | METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | |
| BR112014014869A2 (en) | sulfonylaminopyrrolidinone derivatives, their preparation and their therapeutic application | |
| PH12014501579A1 (en) | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers | |
| BR112015022849A2 (en) | nitroxoline base addition salts and uses thereof | |
| BR112016007238A2 (en) | cyclic thienouracylcarboxamides and their use | |
| MA31902B1 (en) | OXAZOLIDINONES FOR THE TREATMENT AND / OR PROPHYLAXIS OF HEART FAILURE | |
| MA39122B1 (en) | Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors. | |
| ATE527256T1 (en) | SUBSTITUTED (OXAZOLIDINONE-5-YL-METHYL)-2- THIOPHENE CARBOXAMIDES AND THEIR USE IN THE FIELD OF BLOOD CLOTTING | |
| MA37928A1 (en) | Tri (hetero) arylpyrazoles and their use | |
| MA39120A1 (en) | Substituted piperidinyl-tetrahydroquinolines antagonists adrenergic alpha-2c receptors. | |
| EP2377529A4 (en) | USE OF PINOCEMBRIN RACEMATES IN THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF CEREBRAL VASCULAR ACCIDENTS | |
| DE602006020838D1 (en) | MEDICAMENTS FOR PREVENTING OR TREATING HEART FAILURE WITH AN ANTICHOLINERGICUM | |
| EA201200443A1 (en) | COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION | |
| CN105521549A (en) | Medicine applying device for treating beriberi |